{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:40:25Z","timestamp":1772750425485,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund (ERDF)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD), a condition strongly associated with obesity and insulin resistance, is characterized by hepatic lipid accumulation and activation of the endoplasmic reticulum (ER) stress response. The sirtuin 2 (SIRT2) protein deacetylase is emerging as a new player in metabolic homeostasis, but its role in the development of hepatic steatosis and its link with ER stress activation remains unknown. SIRT2-knockout (SIRT2-KO) and wild-type mice were fed either a control or a high-fat diet (HFD) for 4 weeks. Genetic manipulation of SIRT2 levels was performed in human hepatic cells. Although apparently normal under a control diet, SIRT2-KO mice showed accelerated body weight gain and adiposity on a HFD, accompanied by severe insulin resistance. Importantly, SIRT2-KO mice exhibited worsened hepatic steatosis independently from diet, consistent with upregulated gene expression of lipogenic enzymes and increased expression of ER stress markers. Exposure of hepatic cells to palmitate induced lipid accumulation, increased ER stress, and decreased SIRT2 expression. Moreover, SIRT2-silenced cells showed enhanced lipid accumulation and ER stress activation under basal conditions, whereas SIRT2 overexpression abrogated palmitate-induced lipid deposition and ER stress activation. Our findings reveal a role for SIRT2 in the regulation of hepatic lipid homeostasis, potentially through the ER stress response, suggesting that SIRT2 activation might constitute a therapeutic strategy against obesity and its metabolic complications.<\/jats:p>","DOI":"10.3390\/ijms23126790","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T09:51:11Z","timestamp":1655545871000},"page":"6790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway"],"prefix":"10.3390","volume":"23","author":[{"given":"Helena","family":"Leal","sequence":"first","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-4750","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"given":"Patr\u00edcia","family":"Val\u00e9rio","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"given":"Marta","family":"Quatorze","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"given":"V\u00edtor","family":"Carmona","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"given":"Janete","family":"Cunha-Santos","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"given":"Cl\u00e1udia","family":"Pereira","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Medicine, University of Coimbra, 3004-508 Coimbra, Portugal"}]},{"given":"Cl\u00e1udia","family":"Cavadas","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-9133","authenticated-orcid":false,"given":"Pedro","family":"Gomes","sequence":"additional","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Medicine, University of Coimbra, 3004-508 Coimbra, Portugal"},{"name":"Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"841362","DOI":"10.1155\/2012\/841362","article-title":"Endoplasmic reticulum stress and lipid metabolism: Mechanisms and therapeutic potential","volume":"2012","author":"Basseri","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling","volume":"15","author":"Fu","year":"2012","journal-title":"Cell Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrendo.2011.225","article-title":"Sirtuins mediate mammalian metabolic responses to nutrient availability","volume":"8","author":"Chalkiadaki","year":"2012","journal-title":"Nat. Rev. Endocrinology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: Biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd3738","article-title":"Are sirtuins viable targets for improving healthspan and lifespan? Nature reviews","volume":"11","author":"Baur","year":"2012","journal-title":"Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/MCB.23.9.3173-3185.2003","article-title":"Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle","volume":"23","author":"Dryden","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.211342.112","article-title":"The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation","volume":"27","author":"Serrano","year":"2013","journal-title":"Genes Dev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Taylor","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","article-title":"SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C activity","volume":"20","author":"Kim","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.tips.2015.08.001","article-title":"Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism","volume":"36","author":"Gomes","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1101\/gad.180406.111","article-title":"Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system","volume":"26","author":"Krishnan","year":"2012","journal-title":"Genes Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1093\/hmg\/ddx298","article-title":"The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes","volume":"26","author":"Lemos","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.31773","article-title":"SIRT2 prevents liver steatosis and metabolic disorders via deacetylation of HNF4\u03b1","volume":"74","author":"Ren","year":"2021","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lantier, L., Williams, A.S., Hughey, C.C., Bracy, D.P., James, F.D., Ansari, M.A., Gius, D., and Wasserman, D.H. (2018). SIRT2 knockout exacerbates insulin resistance in high fat-fed mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208634"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/dom.13268","article-title":"Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial","volume":"20","author":"Kantartzis","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_26","first-page":"559","article-title":"Effect of resveratrol on non-alcoholic fatty liver disease","volume":"18","author":"Theodotou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/db11-0194","article-title":"Inflammation is necessary for long-term but not short-term high-fat diet\u2013induced insulin resistance","volume":"60","author":"Lee","year":"2011","journal-title":"Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmet.2007.07.003","article-title":"SIRT2 regulates adipocyte differentiation through FoxO1 acetylation\/deacetylation","volume":"6","author":"Jing","year":"2007","journal-title":"Cell Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1091\/mbc.e08-06-0647","article-title":"SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1\u2019s repressive interaction with PPAR\u03b3","volume":"20","author":"Wang","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2017.03.026","article-title":"ATGL Promotes Autophagy\/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism","volume":"19","author":"Sathyanarayan","year":"2017","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1074\/jbc.M113.537266","article-title":"Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin","volume":"289","author":"Ramakrishnan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_32","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7150\/ijbs.6.682","article-title":"Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition","volume":"6","author":"Wang","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2013.10.007","article-title":"SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease","volume":"5","author":"Shin","year":"2013","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","article-title":"SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome","volume":"44","author":"Hirschey","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1073\/pnas.95.11.5987","article-title":"Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice","volume":"95","author":"Horton","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, J., Powell, C.A., Kay, M.K., Sonkar, R., Meruvu, S., and Choudhury, M. (2021). Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-\u03b3 Pathway via miR-27b-5p Regulation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041822"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1210\/en.2011-1881","article-title":"Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: Adaptation with enhanced insulin signaling or insulin resistance","volume":"153","author":"Achard","year":"2012","journal-title":"Endocrinology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.celrep.2017.05.020","article-title":"ER stress inhibits liver fatty acid oxidation while unmitigated stress leads to anorexia-induced lipolysis and both liver and kidney steatosis","volume":"19","author":"Sheldon","year":"2017","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxlet.2012.02.017","article-title":"Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model","volume":"211","author":"Lee","year":"2012","journal-title":"Toxicol. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.201700602R","article-title":"Silybin inhibits NLRP3 inflammasome assembly through the NAD(+)\/SIRT2 pathway in mice with nonalcoholic fatty liver disease","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/BJ20100791","article-title":"Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation","volume":"433","author":"Kendrick","year":"2011","journal-title":"Biochem. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0309-0","article-title":"Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis","volume":"51","author":"Bang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ding, S., Jiang, J., Zhang, G., Bu, Y., Zhang, G., and Zhao, X. (2017). Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183541"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.tips.2019.09.003","article-title":"Dichotomous sirtuins: Implications for drug discovery in neurodegenerative and cardiometabolic diseases","volume":"40","author":"Gomes","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/cdd.2013.104","article-title":"p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene","volume":"20","author":"He","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","article-title":"Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington\u2019s disease","volume":"8","author":"Zala","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1038\/ncomms11445","article-title":"Caloric restriction blocks neuropathology and motor deficits in Machado\u2013Joseph disease mouse models through SIRT1 pathway","volume":"7","author":"Carmona","year":"2016","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/12\/6790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:34:24Z","timestamp":1760139264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/12\/6790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23126790"],"URL":"https:\/\/doi.org\/10.3390\/ijms23126790","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}